Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Dutch Colorectal Cancer Group (DCCG) is a prominent multidisciplinary research collaboration focused on improving the diagnosis and treatment of colorectal cancer in the Netherlands. Established in 1994, the group coordinates large-scale, multicenter clinical trials that have significantly shaped international standards of care, most notably through the CAIRO study series. The DCCG facilitates cooperation among medical oncologists, surgeons, radiotherapists, pathologists, and radiologists across nearly all Dutch hospitals. In addition to interventional trials, the organization manages the Prospective Dutch Colorectal Cancer Cohort (PLCRC), one of the world's largest clinical data and biobank registries for colorectal cancer. Their work is instrumental in advancing personalized medicine and optimizing surgical and systemic therapy outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dutch Colorectal Cancer Group.